The Vanguard Group Disclosure on Spire Healthcare Holdings

The Vanguard Group, Inc. has released a Form 8.3 disclosure concerning its position in Spire Healthcare Group plc. This document is a requirement under Rule 8.3 of the Takeover Code for entities with interests in relevant securities exceeding 1%.

As of June 19, 2026, Vanguard held 14,279,229 ordinary shares of Spire, representing 3.55% of the company's securities. Recent activities include the purchase of 6,837 shares and the sale of 192,037 shares, both at a rate of 2.16 GBP per unit. No cash or stock-settled derivative transactions or new agreements have been reported outside these dealings.

No indemnity or option arrangements or agreements on voting rights have been disclosed. Additionally, there are no supplemental forms attached to this announcement. This clear disclosure maintains transparency as required by the regulatory framework.